VDR and heart disorder: Growing evidence of vitamin D's anti-fibrotic actions may indicate supplementation efforts in the setting of HF, or lead to the development of novel non-calcemic VDR agonists to target VDR signaling for treatment of pathological fibrosis in cardiac disease.